查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1545562

全球辅助生殖技术市场

Assisted Reproductive Technology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球辅助生殖技术市场预计将达276亿美元

全球辅助生殖技术市场预估2023年为197亿美元，预估至2030年将达276亿美元，2023-2030年分析期间复合年增长率为4.9%。体外受精 (IVF) 是本报告分析的细分市场之一，预计复合年增长率为 5.0%，到分析期结束时将达到 220 亿美元。在分析期间，冷冻胚胎交换 (FER) 产业的复合年增长率预计为 4.5%。

美国市场预计53亿美元，中国预计复合年增长率4.8%

预计2023年美国辅助生殖技术市场规模将达53亿美元。中国作为世界第二大经济体，预计2030年市场规模将达44亿美元，2023-2030年分析期间复合年增长率为4.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.6% 和 3.8%。在欧洲，德国的复合年增长率预计为 4.0%。

全球辅助生殖科技市场—主要趋势与驱动因素总结

辅助生殖科技如何改变现代不孕症治疗？

辅助生殖技术 (ART) 正在彻底改变不孕症治疗领域，为数百万受不孕症困扰的个人和夫妻带来希望。 ART 包括用于治疗不孕症的各种医疗程序，其中体外受精 (IVF) 是最知名和最广泛使用的方法。这些技术操纵卵子、精子和胚胎来实现怀孕，为面临自然受孕挑战的人们开闢了新的可能性。卵细胞质内单一精虫显微注射术(ICSI)、胚胎着床前基因检测 (PGT) 和卵子冷冻等技术的进步极大地提高了成功率并扩大了患者的选择。随着 ART 变得越来越复杂，我们不断突破生殖医学的界限，提供满足每位患者独特需求的个人化解决方案。

哪些技术创新将提高ART的成功率？

技术创新在提高辅助生殖技术的成功率并使这些治疗更容易获得和有效方面发挥关键作用。胚胎培养技术的进步，例如使用人工智慧 (AI) 进行延时成像和胚胎品质评估，正在提高选择最有活力的胚胎进行移植的能力，从而增加成功怀孕的可能性。更复杂的荷尔蒙刺激通讯协定的开发也降低了卵巢过度刺激症候群 (OHSS) 的风险，并改善了接受 IVF 患者的治疗结果。此外，冷冻保存的创新，特别是玻璃化技术，显着提高了冷冻卵子和胚胎的存活率，从而实现更灵活的治疗方案和保留生育能力。这些技术进步不仅提高了成功率，而且使 ART 成为更广泛患者的更可靠选择，包括患有复杂不孕症的患者和希望推迟分娩的患者。

哪些市场趋势正在推动辅助生殖技术的采用？

几个关键的市场趋势正在推动辅助生殖技术的采用，反映了社会对计划生育态度的变化和生殖医学的进步。随着职业优先顺序和社会规范的变化，推迟生育的趋势日益明显，这增加了对卵子冷冻等生育力保存选择的需求。此外，同性伴侣和单亲父母对辅助生殖技术的认识和接受程度不断提高，正在扩大不孕症治疗的市场。医疗旅游的成长，特别是在抗爱滋病毒治疗较便宜或某些治疗较容易取得的国家，也有助于抗爱滋病毒治疗服务的全球扩张。此外，随着越来越多的患者寻求适合其独特需求和情况的客製化治疗计划，个人化医疗的趋势正在影响 ART 市场。

推动辅助生殖技术市场成长的因素有哪些？

辅助生殖技术市场的成长是由几个正在改变不孕症治疗格局的因素所推动的。主要影响因素包括因延迟生育、生活方式改变以及影响生殖健康的环境因素导致不孕症盛行率增加。 ART 技术的进步，包括胚胎选择、冷冻保存和基因检测的改进，正在提高成功率，并扩大这些治疗对更广泛患者的吸引力。辅助生殖技术服务在新兴市场的扩展也促进了市场成长，这些市场中不孕症治疗的普及率越来越高。此外，由于生育延迟和计划生育更加灵活的趋势，对保留生育能力选择的需求不断增加，也推动了辅助生殖技术的采用。随着这些因素的不断发展，在技术创新、不断变化的社会规范以及对有效不孕症治疗解决方案日益增长的需求的推动下，辅助生殖技术市场预计将持续成长。

调查企业举例（共11家）

  • Bloom Fertility Centre
  • Cosmos Biomedical Ltd.
  • Cryolab Ltd.
  • European Sperm Bank ApS
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Microm UK Ltd
  • ORIGIO A/S
  • Ovascience Inc.
  • Parallabs Limited

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10397

Global Assisted Reproductive Technology Market to Reach US$27.6 Billion by 2030

The global market for Assisted Reproductive Technology estimated at US$19.7 Billion in the year 2023, is expected to reach US$27.6 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end of the analysis period. Growth in the Frozen Embryo Replacement (FER) segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Billion While China is Forecast to Grow at 4.8% CAGR

The Assisted Reproductive Technology market in the U.S. is estimated at US$5.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Assisted Reproductive Technology Market - Key Trends and Drivers Summarized

How Is Assisted Reproductive Technology Transforming Modern Fertility Treatments?

Assisted Reproductive Technology (ART) has revolutionized the field of fertility treatments, offering hope to millions of individuals and couples struggling with infertility. ART encompasses a range of medical procedures used to treat infertility, with in vitro fertilization (IVF) being the most well-known and widely used method. These technologies involve the manipulation of eggs, sperm, or embryos to achieve pregnancy, and have opened up new possibilities for those facing challenges in conceiving naturally. ART has advanced significantly since its inception, with improvements in techniques such as intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and egg freezing, which have dramatically increased success rates and expanded the options available to patients. As ART becomes more sophisticated, it continues to push the boundaries of what is possible in reproductive medicine, providing personalized solutions that cater to the unique needs of each patient.

What Technological Innovations Are Enhancing the Success Rates of ART?

Technological innovations have played a critical role in enhancing the success rates of Assisted Reproductive Technology, making these treatments more accessible and effective. Advances in embryo culture techniques, such as time-lapse imaging and the use of artificial intelligence (AI) to assess embryo quality, have improved the ability to select the most viable embryos for transfer, increasing the likelihood of a successful pregnancy. The development of more refined hormonal stimulation protocols has also reduced the risk of ovarian hyperstimulation syndrome (OHSS) and improved outcomes for patients undergoing IVF. Additionally, innovations in cryopreservation, particularly vitrification, have significantly improved the survival rates of frozen eggs and embryos, allowing for more flexible treatment schedules and better preservation of reproductive potential. These technological advancements are not only boosting success rates but also making ART a more reliable option for a broader range of patients, including those with complex infertility issues or those who wish to delay childbearing.

What Market Trends Are Driving the Adoption of Assisted Reproductive Technology?

Several key market trends are driving the adoption of Assisted Reproductive Technology, reflecting broader changes in societal attitudes towards family planning and advancements in reproductive medicine. The increasing trend towards delayed parenthood, driven by career priorities and changing social norms, has led to a growing demand for fertility preservation options such as egg freezing, which is now often included as part of ART services. Additionally, the rising awareness and acceptance of ART among same-sex couples and single parents have expanded the market for fertility treatments, as these groups seek options to build their families. The growth of medical tourism, particularly in countries where ART is more affordable or where certain treatments are more readily available, is also contributing to the global expansion of ART services. Furthermore, the ongoing trend towards personalized medicine is influencing the ART market, as patients increasingly seek tailored treatment plans that align with their specific needs and circumstances.

What Factors Are Driving the Growth of the Assisted Reproductive Technology Market?

The growth in the Assisted Reproductive Technology market is driven by several factors that are reshaping the landscape of fertility treatments. A primary driver is the increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle changes, and environmental factors that impact reproductive health. Technological advancements in ART, including improvements in embryo selection, cryopreservation, and genetic testing, are enhancing success rates and broadening the appeal of these treatments to a wider range of patients. The expansion of ART services in emerging markets, where access to fertility treatments is becoming more widespread, is also contributing to market growth. Additionally, the rise in demand for fertility preservation options, driven by trends such as delayed parenthood and the desire for family planning flexibility, is boosting the adoption of ART. As these factors continue to evolve, the ART market is expected to experience sustained growth, driven by innovation, changing societal norms, and the increasing need for effective fertility solutions.

Select Competitors (Total 11 Featured) -

  • Bloom Fertility Centre
  • Cosmos Biomedical Ltd.
  • Cryolab Ltd.
  • European Sperm Bank ApS
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Microm UK Ltd
  • ORIGIO A/S
  • Ovascience Inc.
  • Parallabs Limited

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Assisted Reproductive Technology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Infertility Rates Propel Growth in Assisted Reproductive Technology
    • Advancements in Embryo Selection Strengthen Business Case for ART
    • Increasing Demand for Egg Freezing Expands Addressable Market Opportunity
    • Shift Towards Delayed Parenthood Spurs Growth in Fertility Preservation Services
    • Growth in Same-Sex Couple Family Planning Drives Adoption of ART
    • Innovation in Genetic Testing Techniques Accelerates Demand for Tailored ART Solutions
    • Rising Acceptance of ART Among Single Parents Expands Market Reach
    • Global Medical Tourism Throws the Spotlight on Affordable ART Options
    • Improvement in Cryopreservation Techniques Sustains Growth in ART Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Assisted Reproductive Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Assisted Reproductive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Assisted Reproductive Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for In-Vitro Fertilization (IVF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for In-Vitro Fertilization (IVF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for In-Vitro Fertilization (IVF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Frozen Embryo Replacement (FER) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Frozen Embryo Replacement (FER) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Frozen Embryo Replacement (FER) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Embryo / Egg Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Embryo / Egg Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Embryo / Egg Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • JAPAN
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • CHINA
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • EUROPE
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Assisted Reproductive Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Assisted Reproductive Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • FRANCE
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • GERMANY
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030

IV. COMPETITION